Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca Initiates Study of Antisense Med Targeting PCSK9 to Lower LDL-Cholesterol

americanpharmaceuticalreviewDecember 17, 2020

Tag: PCSK9 , AstraZeneca , ION449 , LDL-C

PharmaSources Customer Service